ReviewActa pharmaceutica Sinica. B2022

Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy.

Xiaoli Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.